1 – 10 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): : initial results from an international prospective study
(
- Contribution to journal › Article
- 2020
-
Mark
FRMD6 has tumor suppressor functions in prostate cancer
2020) In Oncogene(
- Contribution to journal › Article
- 2019
-
Mark
Interim Results from the IMPACT Study : Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
(
- Contribution to journal › Article
- 2018
-
Mark
Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia
(
- Contribution to journal › Article
- 2017
-
Mark
Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility
(
- Contribution to journal › Article
- 2016
-
Mark
The profile feasibility study : Targeted screening of men with a family history of prostate cancer
(
- Contribution to journal › Article
-
Mark
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
(
- Contribution to journal › Article
- 2015
-
Mark
The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers
(
- Contribution to journal › Article
-
Mark
Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.
(
- Contribution to journal › Article